EyePoint Pharmaceuticals Inc. buy Chardan Capital
Start price
07.05.24
/
50%
€9.92
Target price
07.05.25
€25.98
Performance (%)
-14.72%
Price
04.06.24
€8.46
Summary
This prediction is currently active. The prediction for EyePoint Pharmaceuticals Inc. disappoints with a performance of -14.72%. This prediction currently runs until 07.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
EyePoint Pharmaceuticals Inc. | -11.598% |
iShares Core DAX® | -1.226% |
iShares Nasdaq 100 | -1.845% |
iShares Nikkei 225® | -1.132% |
iShares S&P 500 | -0.980% |
Comments by Chardan_Capital for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Chardan Capital from $39.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
03.08.23
03.08.23
€20.11
03.08.24
03.08.24
-13.45%
04.06.24
04.06.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.92
03.03.23
03.03.23
€19.79
03.03.24
03.03.24
797.26%
04.03.24
04.03.24